The reason to this is unknown but one possible explanation could be that increased LOX activity in the tumour-bearing organ, in contrast to the early tumour-promoting role in the tumour microenvironment, could be part of an insufficient defence trying to seal off the tumour. This evidence concerns the gene LOX and neoplasm.